Results 1 to 10 of about 196,709 (242)

Parkinson's disease [PDF]

open access: yesThe Lancet, 2021
Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; the rising prevalence worldwide resembles the many characteristics typically observed during a pandemic, except for an infectious cause.
Bloem, B.R., Okun, M.S., Klein, C.
openaire   +2 more sources

High-Frequency Repetitive Transcranial Magnetic Stimulation Over the Left Dorsolateral Prefrontal Cortex Shortly Alleviates Fatigue in Patients With Multiple System Atrophy: A Randomized Controlled Trial

open access: yesFrontiers in Neurology, 2022
Background: Fatigue is a common symptom in patients with Multiple system atrophy (MSA), but effective treatments remain elusive. The present study aims to investigate whether high-frequency repetitive transcranial magnetic stimulation (rTMS) over the ...
Jing Pan   +10 more
doaj   +1 more source

Parkinson's disease [PDF]

open access: yesThe Lancet, 2004
Parkinson's disease is the most common serious movement disorder in the world, affecting about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons in the substantia nigra, and its cause is enigmatic in most individuals.
Samii, Ali   +2 more
openaire   +3 more sources

Familial Parkinson’s Disease/Parkinsonism [PDF]

open access: yesBioMed Research International, 2015
Parkinson's disease (PD) is the second most common neurodegenerative disorder characterized by parkinsonism (bradykinesia, resting tremor, rigidity, and postural instability) with good response to L-dopa. Although the majority of PD patients are sporadic, it is now clear that genetic factors contribute to the pathogenesis of PD.
Hiroyuki Tomiyama   +3 more
openaire   +3 more sources

Case Report: Progressive Asymmetric Parkinsonism Secondary to CADASIL Without Dementia

open access: yesFrontiers in Neurology, 2022
Parkinsonism is a rare phenotype of cerebral autosomal dominant arteriopathy with subcortical infarction and leukoencephalopathy (CADASIL), all of which involve cognitive decline. Normal cognition has not been reported in previous disease studies.
Weihang Guo   +23 more
doaj   +1 more source

Identification of a DAGLB Mutation in a Non-Chinese Patient with Parkinson's Disease [PDF]

open access: yesMovement Disorders, 2023, 38 (9), pp.1756-1757, 2023
Liu et al. recently reported that biallelic mutations in DAGLB are responsible for autosomal recessive early-onset Parkinson's disease. They identified six patients carrying DAGLB mutations, all of Chinese origin and presenting with typical Parkinson disease.
arxiv   +1 more source

Parkinson′s disease

open access: yesAnnals of Indian Academy of Neurology, 2011
These guidelines present evidence for interventions to manage early stage, uncomplicated Parkinson's Disease. This includes pharmacological and non-pharmacological interventions. The evidence for pharmacological agents to provide neuroprotection or disease modification, such as a delay in disease progression, is discussed, with no trials demonstrating ...
Behari, Madhuri   +11 more
openaire   +8 more sources

Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease

open access: yesFrontiers in Neurology, 2021
Background: Various classifications have been proposed to subtype Parkinson's disease (PD) based on their motor phenotypes. However, the stability of these subtypes has not been properly evaluated.Objective: The goal of this study was to understand the ...
Abhijeet K. Kohat   +33 more
doaj   +1 more source

Deep Learning Predicts Prevalent and Incident Parkinson's Disease From UK Biobank Fundus Imaging [PDF]

open access: yes, 2023
Parkinson's disease is the world's fastest-growing neurological disorder. Research to elucidate the mechanisms of Parkinson's disease and automate diagnostics would greatly improve the treatment of patients with Parkinson's disease. Current diagnostic methods are expensive and have limited availability.
arxiv   +1 more source

Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice.

open access: yesFrontiers in Cellular Neuroscience, 2013
Striatal functions depend on the activity balance between the dopamine and glutamate neurotransmissions. Glutamate inputs activate cyclin-dependent kinase 5 (Cdk5), which inhibits postsynaptic dopamine signaling by phosphorylating DARPP-32 (dopamine- and
Yukio eYamamura   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy